-
Enhabit acquired by Kinderhook for $13.80 per share; goes private
Acquisition of Enhabit by Kinderhook completed at $13.80 per share; aggregate purchase price of approx. $762M.
-
Enhabit stockholders approve merger with Anchor Parent; closing expected May 15
Merger proposal approved with 36,311,910 votes for, 18,275 against, 10,917 abstained.
-
Enhabit supplements proxy disclosures amid three stockholder lawsuits challenging merger with Kinderhook
Three lawsuits filed Apr 21-28, 2026 in NY Supreme Court allege proxy omitted material info on financial projections and Goldman Sachs conflicts.
-
Enhabit sets May 12 stockholder vote for Kinderhook acquisition; HSR waiting period terminated early
Special meeting on May 12, 2026 at 8 a.m. CDT to adopt merger agreement with Anchor Parent, LLC (Kinderhook).
-
Enhabit Q4 revenue $270.4M; Adj. EBITDA $28.0M; pending $13.80/share Kinderhook merger
Net service revenue $270.4M (+4.7% YoY); adjusted EBITDA $28.0M (+11.6% YoY).
-
Enhabit enters $475M credit facility ($315M term loan A, $160M revolver) maturing 2031
$315M term loan A and $160M revolving facility, both due Feb 2031.
-
Enhabit CAO Collin McQuiddy resigns; CFO Ryan Solomon to assume principal accounting officer role
Collin McQuiddy resigns as SVP and Chief Accounting Officer effective March 27, 2026.
-
Enhabit to be acquired by Kinderhook Industries for $13.80/share, ~$1.1B EV
Cash consideration of $13.80 per share, a 24.4% premium to Feb 20 close and 33.8% to 60-day VWAP.
-
Enhabit collects $43.1M settlement in Delaware fiduciary breach case; shares VitalCaring profit stream
Collected $43.1M from former officers Walker, Schuppan, Corey for claims tied to December 2024 judgment finding egregious loyalty breaches.
-
Enhabit to present at BofA conference, update on 2026 pricing impacts
CEO Barbara Jacobsmeyer and CFO Ryan Solomon to participate in fireside chat at BofA Home Care Conference on Dec 9, 2025.
-
Enhabit Q3 revenue $263.6M (+3.9% YoY), Adj. EBITDA $27.0M, raises FY guidance midpoints
Net income $11.1M vs loss of $110.2M; diluted EPS $0.22 (adj. EPS $0.17 vs $0.03).
-
Enhabit management to present at Jefferies Healthcare Services Conference; no material new financial data
CEO Barbara Jacobsmeyer and CFO Ryan Solomon will participate in a fireside chat on Sept 30, 2025 at 10:55 a.m. CT.
-
Enhabit CEO Jacobsmeyer to step down by July 2026; board starts successor search
Barbara Jacobsmeyer will remain President/CEO until successor appointed or July 31, 2026.
-
Enhabit Q2 net rev $266.1M (+2.1% YoY); raises FY2025 guidance
Net service revenue $266.1M (+2.1% YoY); net income $5.2M vs loss $0.2M.
-
Enhabit stockholders approve 2025 Equity Plan with 3.3M share reserve
Stockholders approved Enhabit 2025 Equity and Incentive Compensation Plan at June 26 annual meeting.
-
Enhabit to present at Goldman Sachs Healthcare Conference on June 10, 2025
CEO Barbara Jacobsmeyer and CFO Ryan Solomon to participate in fireside chat at Goldman Sachs 46th Annual Global Healthcare Conference.
-
Enhabit Q1 net income $17.8M, adj EBITDA $26.6M; leverage ratio below 4.5x
Net service revenue $259.9M (-1% YoY); home health -5.9%, hospice +20.5%.
-
Enhabit sells Medalogix stake for $21M; proceeds to reduce debt
Sold its investment in Medalogix as part of a private equity-backed combination with Forcura.
-
Enhabit Q4 net loss $46M on $53.8M goodwill impairment; hospice revenue up 13% YoY; issues FY2025 guidance
Net loss $46.0M (diluted EPS -$0.92) vs loss $6.4M a year ago; includes $53.8M non-cash goodwill impairment.
-
Enhabit nominates former AccentCare CEO Stephan Rodgers to board
Stephan Rodgers, former CEO of AccentCare (home health & hospice), nominated to Enhabit's board.
-
Enhabit signs multi-year agreement with UnitedHealthcare for home health services, effective Jan 1, 2025
New multi-year agreement with UnitedHealthcare ensures continued in-network access for UHC members.
-
Enhabit & Encompass win lawsuit; awarded 43% of VitalCaring Group profits
Court found three former officers and Vistria/Nautic aided egregious breaches of duty of loyalty.
-
Enhabit (EHAB) appoints Ryan Solomon as CFO effective Dec 9, 2024
Ryan Solomon named CFO; succeeds Crissy Carlisle as part of planned transition.
-
Enhabit Q3 net loss $110.2M, adjusted EBITDA $24.5M, guides revenue down
Net loss $110.2M ($2.20 EPS); adjusted EPS $0.03; revenue $253.6M, down 1.8% YoY.
-
Enhabit appoints Collin McQuiddy as Senior VP and Chief Accounting Officer
Collin McQuiddy appointed Senior Vice President and Chief Accounting Officer, effective August 5, 2024.
-
Enhabit Q2 net loss $0.2M; adj. EBITDA $25.2M; guides 2024 revenue $1.05-1.063B
Net loss $0.2M (diluted EPS $0.00); adj. EPS $0.07; adj. EBITDA $25.2M, up 5.4% YoY.
-
Enhabit CFO Crissy Carlisle to step down by Dec 31, 2024
CFO Crissy Carlisle's employment ends Dec 31, 2024 or earlier; separation agreement filed as Exhibit 10.1.
-
Enhabit annual meeting: dissident nominee Ohlendorf elected, incumbent La Monica ousted
Mark Ohlendorf (AREX dissident slate) elected with 20.6M for votes; Susan La Monica (company) not elected with 17.7M for, 24.2M withheld.
-
Enhabit announces preliminary voting results; AREX Capital nominee elected to board
Preliminary count shows eight of Enhabit's director nominees elected (Bolton, Brown-Stevenson, Elson, Hoeflinger, Jacobsmeyer, McGuigan, Rush, Schochet).
-
Enhabit prelim Q2 2024 adj. EBITDA $24.5-25.0M, reduces debt $15M, admissions up 6.4% YoY
Adjusted EBITDA guidance of $24.5M-$25.0M for Q2 2024.
-
Enhabit to present at Goldman Sachs Healthcare Conference; no material updates disclosed
CEO Barbara Jacobsmeyer and CFO Crissy Carlisle to participate in fireside chat on June 11, 2024 at 10 a.m. EDT.
-
Enhabit concludes strategic review without sale; Q1 rev $262.4M, Adj. EBITDA $25.3M
Board ends strategic alternatives review, will remain independent; no formal proposals received.
-
Enhabit Q4 net loss $6.4M, adjusted EPS $0.06; FY2024 guidance expects $98-$110M EBITDA
Q4 net service revenue $260.6M (-1% YoY); net loss $6.4M vs $95.2M loss in prior year (includes $109M goodwill impairment then).
-
Enhabit Q3 net loss $2.4M; cuts 2023 guidance; amends credit covenant to 6.75x
Q3 net service revenue $258.3M (down 2.8% YoY); adjusted EBITDA $23.2M (down 26.8%); adjusted EPS $0.03 vs $0.19.
-
Enhabit schedules Q3 2023 earnings release Nov 7; liquidity ~$80M as of Sept 30
Q3 2023 results to be released Nov 7; earnings call Nov 8 at 10:00 AM ET.
-
Enhabit obtains covenant waiver for Q3 2023; revolver cut to $230M
Limited Waiver exempts compliance with Total Net Leverage Ratio and Interest Coverage Ratio as of Sept 30, 2023 test date.
-
Enhabit Q2 net loss $74.1M; cuts FY23 guidance; plans strategic alternatives process
Q2 net loss $74.1M ($1.49 diluted loss per share); adjusted EPS $0.04, down 91.5% YoY.
-
Enhabit shareholders elect 13 directors, ratify PwC, approve say-on-pay at 2023 annual meeting
Turnout: 46.7M shares (93.13% of outstanding) voted at June 28, 2023 annual meeting.
-
Enhabit amends credit agreement to raise leverage caps and restrict dividends
Maximum Total Net Leverage Ratio raised to 5.25x through Dec 2023, stepping to 4.50x by Sep 2024.
-
Enhabit Q1 revenue $265.1M, Adj EBITDA down 46% YoY; reaffirms FY guidance
Q1 net service revenue $265.1M (-3.4% YoY); net income $3.2M ($0.05 EPS), adjusted EPS $0.09 vs $0.56 prior.
-
Enhabit corrects Q4 2022 results: net loss $94.7M, revenue down 4.7% YoY
Corrected Q4 2022 net loss of $94.7M ($1.91 loss per diluted share); adjusted EPS $0.17.
-
Enhabit delays FY2022 10-K, discloses $12M AR understatement and material weakness
Company unable to file FY2022 10-K by due date; goodwill impairment analysis not finalized.
-
Enhabit appoints McGuigan and Schochet to board under cooperation agreement with activist investors
Board expanded to 13 directors; Stuart McGuigan and Barry Schochet appointed immediately.
-
Enhabit amends executive severance and change-in-control plans, reducing benefits for named officers
Reduces cash severance for CEO from 2.99x to 2.5x base salary; for CFO and EVP from 2x to 1.75x.
-
Enhabit Q4 net income down 72.5% to $8.2M; guides FY23 adj EBITDA $125-140M
Net service revenue $275.1M (-0.4% YoY); adj EBITDA $40.3M (-17.8% YoY).
-
Enhabit Q3 net revenue $265.7M (-3% YoY); cuts FY 2022 guidance across all metrics
Net revenue $265.7M (-3% YoY); net income $8.6M (-60.2%); adjusted EPS $0.19 vs $0.50.
-
Enhabit General Counsel Chad Knight to step down on Nov 4, 2022
General Counsel Chad K. Knight will step down effective November 4, 2022.
-
Enhabit files 8-K reporting Q2 2022 results; specific figures not available in provided text
Press release and supplemental information furnished as exhibits but not included in the filing text.
-
Enhabit completes spin-off from Encompass Health, trades as EHAB; borrows $570M, appoints two directors
Spin-off effective July 1, 2022; Encompass shareholders received 1 EHAB share per 2 Encompass shares.
-
Enhabit spin-off from Encompass cleared; distribution 1-for-2 on July 1
Registration statement on Form 10 became effective June 17, 2022.